21647 ⎘
Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups -
Anti-amyloid beta antibodies binding to a cyclic amyloid beta peptide
#1502Pyrazoline dihydroquinolones, pharmaceutical compositions, and uses
#1503Drug delivery devices and methods of making and using same
#1504Analgesic preparation with nanocarriers and use thereof
#1505Stable Anti-inflammatory Solutions for Injection
#1506X-RAY psoralen activated cancer therapy (X-PACT) with associated treatments
#1507Vaccines against an oncogenic isoform of HER2 (ErbB2) and methods of using the same
#1508Composition and therapeutic anti-tumour vaccine
#1509Compositions and methods for counteracting Factor Xa inhibition
#1510Agent for use in the case of fructose intolerance
#1511Methods and compositions for treatment of bone, skin, subcutaneous, mucosal and/or submucosal cancer by percutaneous and/or transmucosal administration of interferon
#1512Il-2Rβ-selective agonists in combination with an anti-CTLA-4 antibody or an anti-PD-1 antibody
#1513Pharmaceutical formulation for bedwetting and method of use thereof
#1514METHODS OF TREATING MYELOID LEUKEMIA
#1515METHODS FOR TREATMENT OF ATHEROSCLEROSIS
#1516Use of whey protein micelles and polysaccharides for improving insulin profile
#1517Pharmaceutical kit comprising erythrocytes encapsulating a PLP-dependent enzyme and, a non-phosphate PLP precursor
#1518Diagnostic methods for T cell therapy
#1519Compositions and methods for inducing beige or brown fat tissue
#1520METHODS FOR THE TREATMENT AND PREVENTION OF RENAL DISORDERS AND FATTY LIVER DISORDERS
#1521Composition for treating neuropathy, process and method of treatment thereof
#1522METHODS AND COMPOSITIONS FOR PREVENTING OR TREATING CHRONIC INFLAMMATORY DISEASES
#1523METHODS OF TREATMENT OF ANORECTAL AND GENITAL DISORDERS
#1524ANTIDIABETIC MEDICATIONS
#1525Treatment of B-cell malignancies by a combination JAK and PI3K inhibitors
#15264,6-pyrimidinylene derivatives and uses thereof
#1527METHODS FOR REDUCING THE RISK OF AN ADVERSE TERIFLUNOMIDE AND ROSUVASTATIN INTERACTION IN MULTIPLE SCLEROSIS PATIENTS
#1528COMBINATION OF MORPHINAN COMPOUNDS AND ANTIDEPRESSANT FOR THE TREATMENT OF PSEUDOBULBAR AFFECT, NEUROLOGICAL DISEASES, INTRACTABLE AND CHRONIC PAIN AND BRAIN INJURY
#1529Combination therapy
#1530Combination of oxymetazoline and ipratropium in topical nasal application for the treatment of a cough
#1531Medicinal Treatment of Chronic Inflammatory Dermal Disorders
#1532METHOD OF TREATING HYPERTENSION
#1533Topical nifedipine formulations and uses thereof
#1534Use of gaboxadol in the treatment of tinnitus
#1535METHODS AND COMPOSITIONS FOR TREATMENT OF EPILEPTIC DISORDERS
#1536Combination therapy with nitrated lipids and inhibitors of the renin-angiotensin-aldosterone system
#1537ENZALUTAMIDE IN COMBINATION WITH AFURESERTIB FOR THE TREATMENT OF CANCER
#1538Veterinary formulations
#1539Complex of a glucopyranosyl derivative and preparation method and use thereof
#1540MICROENCAPSULATED CANNABINOID COMPOSITIONS
#1541COMPOSITIONS AND METHODS FOR TREATING ISCHEMIC STROKE
#1542COMPOUNDS CONTAINING S-N-VALERYL-N-{[2'-(1H-TETRAZOLE-5-YL)-BIPHENYL-4-YL]-METHYL}-VALINE AND (2R,4S)-5-BIPHENYL-4-YL-4-(3-CARBOXY-PROPIONYLAMINO)-2-METHYL-PENTANOIC ACID ETHYL ESTER MOIETIES AND CATIONS
#1543TOPICAL ANALGESIC PAIN RELIEF FORMULATIONS, MANUFACTURE AND METHODS OF USE THEREOF
#1544PHARMACEUTICAL FORMULATION FOR REDUCING BLADDER SPASMS AND METHOD OF USE THEREOF
#1545COMPOSITIONS FOR TISSUE STABILIZATION
#1546Cannabis oil compositions and methods for preparation thereof
#1547Nanoparticles for treatment of posterior segment ocular diseases and conditions
#1548PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF
#1549Cannabinoid formulations for inhalation
#1550BIARYL MONOBACTAM COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF BACTERIAL INFECTIONS
#1551Dimethyl-nonatetraenyl-trimethyl-cyclohexyl compounds and uses thereof
#1552METHODS OF ADMINISTERING NITRIC OXIDE TO ARTERIAL OR ARTERIALIZED BLOOD
#1553Antibodies, pharmaceutical compositions and methods
#1554Copper-cysteamine and methods of use
#1555MODIFIED ANTIBODIES
#1556PHARMACEUTICAL COMBINATION FOR IMPROVING GLYCEMIC CONTROL AS ADD-ON THERAPY TO BASAL INSULIN
#1557GLYCOPROTEINS HAVING LIPID MOBILIZING PROPERTIES AND THERAPEUTIC USES THEREOF
#1558METHODS FOR TREATMENT OF ATHEROSCLEROSIS
#1559Use of short synthetic peptide for the treatment and/or prophylaxis of dry eye disease
#1560Compositions for treating neurological disorders
#1561Formulations for treatment of post-traumatic stress disorder
#1562Method of Adjuvant Cancer Treatment
#1563Pyrimidine derivative and use thereof
#15643-(PIPERIDIN-4-YL)-ISOXAZOL-3(OH)-ONES FOR TREATMENT OF DERMATOLOGIC DISORDERS
#1565COMBINED THERAPY FOR NMDAR ANTAGONIST-RESPONSIVE NEUROPSYCHIATRIC DISORDERS
#1566Compositions and Methods for Non-Surgical Treatment of Ptosis
#1567Pharmaceutical compositions comprising levodopa, a dopamine decarboxylase inhibitor and a COMT inhibitor and method of administration thereof
#1568POSITION-SPECIFIC ASYMMETRIC DEUTERIUM ENRICHED CATECHOLAMINE DERIVATIVES AND MEDICAMENTS COMPRISING SAID COMPOUNDS
#1569Compositions comprising citrulline and leucine and their use in the treatment of diabetes and metabolic syndrome
#1570RECEPTOR SUBTYPE AND FUNCTION SELECTIVE RETINOID AND REXINOID COMPOUNDS IN COMBINATION WITH IMMUNE MODULATORS FOR CANCER IMMUNOTHERAPY
#1571Methods and Compositions for the Treatment and Prevention of Allergic Rhinitis
#1572Combination therapy for metastatic cancer
#1573COMPOSITIONS AND METHODS OF TREATMENT FOR MVID AND RELATED DISEASES
#1574Use of cannabinoids in the treatment of epilepsy
#1575Compositions for delivery of drug combinations
#1576ANTIMICROBIAL COMPOUNDS AND COMPOSITIONS, AND USES THEREOF
#1577Biologic composition and method of manufacture
#1578USE OF COMPLEMENT PATHWAY INHIBITORS TO TREAT OCULAR DISEASES
#1579ANTI-FOLR1 IMMUNOCONJUGATES AND ANTI-PD-1 ANTIBODY COMBINATIONS
#1580INHIBITION OF TISSUE FACTOR PATHWAY INHIBITOR WITH FACTOR XA DERIVATIVES
#1581METHODS OF USING INTERLEUKIN-10 FOR TREATING DISEASES AND DISORDERS
#1582Oxysterol-statin compounds for bone growth
#1583Ophthalmic compositions and methods of use
#1584Pharmaceutical composition containing 2-{4-[N-(5,6-diphenylpyrazin-2-yl)-N-isopropylamino]butyloxy}-N-(methylsulfonyl)acetamide
#1585BENZONAPTHYRIDINE COMPOSITIONS AND USES THEREOF
#1586Combination therapy
#1587METHODS OF TREATING LIVER DISEASE
#1588METHOD OF WEIGHT REDUCTION
#1589Compositions and methods employing FtsZ as a target for Albendazole sulfone
#1590COMPOSITIONS AND METHODS FOR TREATING PRESBYOPIA, MILD HYPEROPIA, AND IRREGULAR ASTIGMATISM
#1591VITAMIN E COMPOSITIONS AND METHODS OF USE THEREFOR
#1592Composition and medical product for reducing body weight and body fat, and use of said product
#1593Product comprising red clover extract and methods for producing the same
#1594AGENTS USEFUL FOR TREATING FRIEDREICH'S ATAXIA AND OTHER NEURODEGENERATIVE DISEASES
#1595Methods for treating cancer
#1596More potent and less toxic formulations of epinephrine and methods of medical use
#1597Patches and Methods for the Transdermal Delivery of a Therapeutically Effective Amount of Iron
#1598Pharmaceutical compositions for treating or preventing pain
#1599Combination therapy with anti-HLA-DR antibodies and kinase inhibitors in hematopoietic cancers
#1600AROMATIC-CATIONIC PEPTIDES AND METHODS FOR USING SAME
#1601Nanoparticles, process for preparation and use thereof as carrier for amphipatic and hydrophobic molecules in fields of medicine including cancer treatment and food related compounds
#1602Crystalline forms of a Bruton's tyrosine kinase inhibitor
#1603[1,2,4]triazolo[1,5-a]pyrimidin-7-yl compound
#1604MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS
#1605Long-term memory inducing agent
#1606New A-PRP Medical Device & Tissue Engineering Composition, Manufacturing Machines And Process
#1607Formulations containing clopidogrel and sulfoalkyl ether cyclodextrin and methods of use
#1608Semifluorinated alkane compositions
#1609Combination therapy involving antibodies against Claudin 18.2 for treatment of cancer
#1610Bispecific antibodies specifically binding to PD1 and LAG3
#1611Cancer treatment composition combining anti-CD26 antibody and other anticancer agent
#1612CD200 inhibitors and methods of use thereof
#1613EPITOPES IN AMYLOID BETA AND CONFORMATIONALLY-SELECTIVE ANTIBODIES THERETO
#1614COMPOSITIONS AND METHODS FOR IMPROVING HEART FUNCTION AND TREATING HEART FAILURE
#1615PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT OF DIABETES
#1616METHOD FOR TREATING TUMOR BY USING RECOMBINANT INTERFERON WITH CHANGED SPATIAL CONFIGURATION
#1617Prevention and treatment of ocular side effects with a cyclosporin
#1618Collagen peptide-based medicament compositions and devices and methods of production and use thereof
#1619Drug combinations and uses in treating a coughing condition
#1620Composition for treatment of damaged part
#1621MULTICOMPONENT ORAL CARE COMPOSITION
#1622Method of treating bacterial infections
#1623Compositions comprising decitabine and tetrahydrouridine and uses thereof
#1624Amido-substituted pyridotriazine derivatives useful as HIV integrase inhibitors
#1625Spirocyclic Pyridotriazine Derivatives useful as HIV integrase inhibitors
#1626System and Method for Diagnosis and Treatment
#1627METHODS AND COMPOSITIONS FOR TREATING PULMONARY HYPERTENSION
#1628Administration of NEDD8-activating enzyme inhibitor and chemotherapeutic agents
#1629Therapeutic methods and compositions
#1630COMPOSITIONS AND METHODS RELATING TO CANCER
#1631Pharmaceutical composition containing 2-{4-[N-(5,6-diphenylpyrazin-2-yl)-N-isopropylamino]butyloxy]-N-(methylsulfonyl)acetamide
#1632COMBINATIONS COMPRISING BREXPIPRAZOLE OR A SALT THEREOF AND A SECOND DRUG FOR USE IN THE TREATMENT OF A CNS DISORDER
#1633SUBACUTE ADMINISTRATION OF NMDA MODULATORS ALONE OR IN COMBINATION
#1634Methods and pharmaceutical compostions for treating rhabdomyolysis
#1635IMMUNOREGULATORY AGENTS
#1636METHODS AND DEVICES FOR THE TREATMENT OF OCULAR DISEASES IN HUMAN SUBJECTS
#1637Use of 2-carboxamide cycloamino urea derivatives in the treatment of EGFR dependent diseases or diseases that have acquired resistance to agents that target EGFR family members
#1638Methods for treatment of Fabry disease
#1639Use of maleimide derivatives for preventing and treating cancer
#1640Antimicrobial compositions for
#1641Stable analogs of CYP450 lipid metabolites and inhibitors of soluble epoxide hydrolase
#1642CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER
#1643USE OF PROTEASOME INHIBITORS TO TREAT OCULAR DISORDERS
#1644BENZOQUINONE DERIVATIVE E3330 IN COMBINATION WITH CHEMOTHERAPEUTIC AGENTS FOR THE TREATMENT OF COLON CANCER
#1645Transdermally-delivered combination drug therapy for pain
#1646PHARMACEUTICAL FORMULATION FOR REDUCING FREQUENCY OF URINATION AND METHOD OF USE THEREOF
#1647Pharmacological prophylactics against stress-induced affective disorders and their associated symptoms
#1648Millicapsule formulations comprising polyunsaturated free fatty acids
#1649Uses of milrinone controlled-release formulation
#1650Process for preparing a dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic
#1651Process for preparing a dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic
#1652Formulations for controlled release of bupivacaine
#1653A DIETARY SUPPLEMENT COMPRISING BETA-GLUCAN AND CASEIN HYDROLSATE FOR IMPROVING HEALTH AND GROWTH PERFORMANCE IN A MAMMAL
#1654Soluble MANF in pancreatic beta-cell disorders
#1655Identification of Novel Small Molecule Beta2 Integrin Agonists
#1656Anti-amyloid beta antibodies binding to a cyclic amyloid beta peptide
#1657Crystalline forms of a bruton's tyrosine kinase inhibitor
#1658CRYSTALLINE FORMS OF A BRUTON'S TYROSINE KINASE INHIBITOR
#1659N-pyridinyl acetamide derivatives as inhibitors of the WNT signaling pathway
#1660Ferroportin inhibitors
#1661Heteroarylcarboxamide derivatives as plasma kallikrein inhibitors
#1662Aminonapthoquinone compounds and pharmaceutical composition for blocking ubiquitination-proteasome system in diseases
#1663Kinase inhibitors
#1664Composition comprising hyaluronic acid and mepivacaine
#1665Method for determining presence or absence of suffering from malignant lymphoma or leukemia, and agent for treatment and/or prevention of leukemia
#1666Glypican 2 as a cancer marker and therapeutic target
#1667Formulation of nanostructured gels for increased agent loading and adhesion
#1668Methods for the treatment of recurrent glioblastoma (RGBM)
#1669Compositions and methods for treatment of homocystinuria
#1670COMPOSITIONS AND METHODS COMPRISING SERRATIA PEPTIDASE FOR INHIBITION AND TREATMENT OF BIOFILMS RELATED TO CERTAIN CONDITIONS
#1671NMDAR antagonists for the treatment of diseases associated with angiogenesis
#1672Compositions and methods for sensitizing low responsive tumors to cancer therapy
#1673PEPTIDES AND METHODS OF TREATING ENDOMETRIOSIS USING THE SAME
#1674Therapy and kit for the prevention and treatment of cystic fibrosis
#1675Multidimensional approach for Cancer treatment
#1676Transfer factor preparations and associated methods
#1677Honey-cannabinoid therapeutic composition
#1678METHODS AND COMPOSITIONS FOR IMPROVED TISSUE REGENERATION BY SUPPRESION OF INTERFERIN-GAMMA AND TUMOR NECROSIS FACTOR-ALPHA
#1679Mesenchymal stem cell-derived exosomes and their uses
#1680METHODS FOR TREATING CANCER
#1681Methods of inhibiting the virulence of a pathogen with an oxidized tannin to treat a gastrointestinal spasm
#1682DRUG CONTAINING CATIONIZED CHITOSAN
#1683Composition based on xyloglucan and proteins for the treatment of intestinal disorders
#1684Compositions and methods of treating acne and photoaging
#1685Therapy for inhibition of single-stranded RNA virus replication
#1686ANTI-AGING COMPOSITIONS AND METHODS FOR USING SAME
#1687Dosing regimen for sedation with CNS 7056 (Remimazolam)
#1688ANTITUMOR AGENT
#1689Treatments for resistant acne
#1690METHODS OF TREATING TRANSPLANT REJECTION
#1691COMBINATION OF AN ALK INHIBITOR AND A CDK INHIBITOR FOR THE TREATMENT OF CELL PROLIFERATIVE DISEASES
#1692TREATMENTS FOR DEPRESSION AND OTHER DISEASES WITH A LOW DOSE AGENT
#1693Glutamate agents in the treatment of mental disorders
#1694Imidazo[4,5-c]quinolin-2-one Compounds and Their Use in Treating Cancer
#1695Pharmaceutical composition, use of mefloquine in fixed dose, and method for treating tuberculosis
#1696COMBINATION THERAPY USING PI3K INHIBITOR AND MDM2 INHIBITOR
#1697METHOD FOR IMPROVING PHARMACOKINETICS
#1698Ophthalmic pharmaceutical compositions and uses relating thereto
#1699Use of composition for preparing a medicament for treatment of amyotrophic lateral sclerosis
#1700PDE4 modulators for treating and preventing immune reconstitution inflammatory syndrome (IRIS)
#1701PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF
#1702Modified release orally administered amino acid formulations
#1703TREATMENT OF NERVOUS SYSTEM DISORDERS USING THYROID HORMONE NEUTRAL DOSES OF RXR AGONISTS
#1704Zeaxanthin for Tumor Treatment
#1705PURGATIVE COMPOSITION FOR CLEANSING INTESTINAL TRACT
#1706Inhalable Pharmaceutical Compositions
#1707SNS-595 AND METHODS OF USING THE SAME
#1708Inhibition of innate immune response
#1709METHODS FOR TREATING REFRACTORY ANEMIA WITH RINGED SIDEROBLASTS
#1710Compositions and methods for ceramide-elevating therapeutic strategies
#1711Benzopiperazine compositions as BET bromodomain inhibitors
#1712KDM1A inhibitors for the treatment of disease
#1713A Medical Composition and a Medical Hydrogel for Use in the Prevention and/or Treatment of a Disease of the Facet Joints and/or for Use in the Replacement and/or Regeneration of Articular Facets
#1714Compositions
#1715Methods for radiotherapy to trigger light activation drugs
#1716PROGNOSIS AND TREATMENT OF SQUAMOUS CELL CARCINOMAS
#1717Chemically modified cystathionine beta-synthase enzyme for treatment of homocystinuria
#1718INJECTABLE SOLUTION AT PH 7 COMPRISING AT LEAST ONE BASAL INSULIN WHOSE PI IS BETWEEN 5.8 AND 8.5
#1719Glucokinase activator compositions for the treatment of diabetes
#1720Composition having tissue-repairing activity, and use therefor
#1721METHODS OF TREATING MYELOID LEUKEMIA
#1722METHODS FOR TREATING HYPOTENSION
#1723PHARMACEUTICAL COMPOSITION FOR INCREASING CONTENT AND AVAILABILITY OF CYCLIC ADENOSINE MONOPHOSPHATE IN A BODY AND PREPARATION THEREOF
#1724Bioeffective krill oil compositions
#1725Primed muscle progenitor cells and uses thereof
#1726IN SITU NEUTRALIZATION COMPOSITION
#1727Compositions and methods for treating joints
#1728Methods for treating Filoviridae virus infections
#1729Methods of treating advanced prostate cancer
#1730METHOD OF TREATING PATIENTS COADMINISTERED A FACTOR Xa INHIBITOR AND VERAPAMIL
#1731Combination therapy for treating malignancies
#1732USE OF A COMBINATIONAL THERAPY OF LSD1 INHIBITORS WITH CDK2 INHIBITORS IN THE TREATMENT OF CANCER
#1733PHARMACEUTICAL SYNERGISTIC COMBINATION
#1734Selective Agonist Of a6 Containing nAChRs
#1735Pharmaceutical combination of opioid and prostaglandin compound
#1736Triple combination
#1737DESETHYLHYDROXYCHLOROQUINE FOR THE TREATMENT OF DISEASES ASSOCIATED WITH INFLAMMATION
#1738USE OF LAQUINIMOD TO DELAY HUNTINGTON'S DISEASE PROGRESSION
#1739Pharmaceutical composition and uses thereof
#1740EXTERNAL PREPARATION
#1741TREATMENT OF CANCERS WITH ACQUIRED RESISTANCE TO KIT INHIBITORS
#1742METHODS OF TREATMENT AND COMPOSITIONS WITH XANTHINE OXIDASE INHIBITORS
#1743Pharmaceutical Composition Comprising Deferasirox
#1744Use of cannabinoids and terpenes for treatment of organophosphate and carbamate toxicity
#1745COMBINATION TREATMENT FOR INFLAMMATORY DISEASES
#1746Composition of chlorogenic acid and methods of making and using the same in treating serum lipid levels
#1747Method for improving recognition and/or working memory in hyperphenylalanimenia and phenylketonuria patients
#1748NEW COMBINATION THERAPIES FOR TREATING NEUROLOGICAL DAMAGE
#1749Anti-fungal compositions for treating nails and methods for fabricating and using thereof
#1750PHARMACEUTICAL FORMULATION FOR BEDWETTING AND METHOD OF USE THEREOF
#1751Pharmaceutical composition containing clomipramine and preparation method therefor
#1752Multiphasic compositions
#1753INFANT FORMULA WITH MILK FAT FOR PROMOTING HEALTHY GROWTH
#1754Methods and compositions relating to proteasome inhibitor resistance
#1755Bacterial toxins and uses thereof as Ras specific proteases for treating cell proliferation diseases and disorders
#1756Pharmaceutical compositions of compound
#1757COMT inhibiting methods and compositions
#1758Bicyclic compounds and their use as antibacterial agents and β-lactamase inhibitors
#17596-[5-amino-6-(2-ethoxyethoxy)-imidazo[4,5-B]pyridin-3-yl]-nicotinonitrile derivatives and their use as IRAK inhibitors
#1760COMPOSITIONS AND METHODS FOR ENHANCING ONCOLYTIC VIRUS EFFICACY
#1761Synergistic compositions
#17622-beta-naphthyl-acetic acid analogs as AKR1C3 inhibitors and methods of using same
#1763Polymer conjugate comprising a bioactive agent
#1764A NANOMATERIAL COMPLEX COMPRISING GRAPHENE OXIDE ASSOCIATED WITH A THERAPEUTIC AGENT AND METHODS OF USE
#1765Regulatory T cell PD-1 modulation for regulating T cell effector immune responses
#1766Use of immunomodulatory kits for immunotherapeutic treatment of patients with myeloid leukemias
#1767Notch1 Decoy Antagonists Protect From Obesity-Induced Insulin Resistance and Fatty Liver
#1768HU specific interfering agents
#1769Specific nutritional or therapeutic agent including a mixture of grape and blueberry
#1770Composition for prevention, alleviation, or treatment of peripheral neuropathy comprising Lithospermi Radix extract as an effective component
#1771TREATMENT FOR INFECTION COMPOSED OF MENSTRUAL STEM CELLS
#1772Compositions and Methods for the Prevention of Microbial Infections
#1773Methods of using ophthalmic compositions comprising povidone-iodine
#1774Pharmaceutical Composition for Treating STK11-Mutation Cancer Using Cardiac Glycosides
#1775Inhibitors of diacylglycerol O-acyltransferase 1 (DGAT-1) and uses thereof
#1776Effervescent formulation based on pyridoxal-5-phosphate
#1777Pharmaceutical compositions and methods for anesthesiological applications
#1778BISMUTH-THIOLS AS ANTISEPTICS FOR BIOMEDICAL USES, INCLUDING TREATMENT OF BACTERIAL BIOFILMS AND OTHER USES
#1779Controlled-release tozadenant formulations
#1780Combination therapy for treating malignancies
#1781TRANSIENT PROTECTION OF HEMATOPOIETIC STEM AND PROGENITOR CELLS AGAINST IONIZING RADIATION
#1782THERAPEUTIC REGIMEN
#1783CANCERS EXPRESSING CCR5 AND METHODS OF TREATMENT OF SAME
#1784COMPOSITIONS COMPRISING NICOTINIC AGONISTS AND METHODS OF USING SAME
#1785Combination of Bcl-2 inhibitor and MEK inhibitor for the treatment of cancer
#1786METHODS AND COMPOSITIONS FOR ENHANCING FEMALE SEXUAL AROUSAL AND TREATING FEMALE SEXUAL DYSFUNCTION
#1787Dosage and formulation
#1788Methods of treating hepatic encephalopathy
#1789UNIT ORAL SOLID DOSE COMPOSITIONS COMPOSED OF IBUPROFEN AND NIZATIDINE
#1790SUBSITUTED ALIPHANES, CYCLOPHANES, HETERAPHANES, HETEROPHANES, HETERO-HETERAPHANES AND METALLOCENES USEFUL FOR TREATING HCV INFECTIONS
#1791METHODS AND COMPOSITIONS FOR TREATING TRAUMATIC BRAIN INJURY
#1792Entacapone for treatment of obesity
#1793Omega-3 compositions, dosage forms, and methods of use
#1794Compositions and methods for treating retinopathy
#1795Methods of reducing risk of cardiovascular disease
#1796Supporting immunomodulatory agent
#1797Combination comprising an aminothiolester compound or a pharmaceutically acceptable salt thereof and a compound able to increase the H2O2 level in cancer cells of a subject
#1798Intravenous administration of tramadol
#1799Inhibition of multiple pathogenic agents using bithionol
#1800Design, synthesis and methods of use of acyclic fleximer nucleoside analogues having anti-coronavirus activity